MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+15.57%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$296M
AUM Growth
+$296M
(-5.4%)
Cap. Flow
-$53.5M
Cap. Flow
% of AUM
-18.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $159M | 53.64% | 19,963,157 | – | – |
|
2
Merus
MRUS
$4.98B
| $44M | 14.85% | 1,600,000 | – | – |
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $34.3M | 11.59% | 3,760,869 | – | – |
|
4
NewAmsterdam Pharma
NAMS
$2.71B
| $32.1M | 10.82% | 2,869,565 | – | – |
|
5
Aura Biosciences
AURA
$389M
| $26.9M | 9.09% | 3,039,892 | – | – |
|
6
Vaxcyte
PCVX
$4B
| – | – | -1,049,893 | Closed | -$53.5M |
|